Pfizer PGN 165 (Lyrica CR 165 mg)
Generic Name: pregabalin
Pill with imprint Pfizer PGN 165 is Beige, Elliptical/Oval and has been identified as Lyrica CR 165 mg. It is supplied by Pfizer Inc.
Lyrica CR is used in the treatment of neuropathic pain; diabetic peripheral neuropathy; postherpetic neuralgia and belongs to the drug class gamma-aminobutyric acid analogs. Risk cannot be ruled out during pregnancy. Lyrica CR 165 mg is classified as a Schedule 5 controlled substance under the Controlled Substance Act (CSA).
Images for Pfizer PGN 165
Lyrica CR
- Generic Name
- pregabalin
- Imprint
- Pfizer PGN 165
- Strength
- 165 mg
- Color
- Beige
- Size
- 18.00 mm
- Shape
- Elliptical/Oval
- Availability
- Prescription only
- Drug Class
- Gamma-aminobutyric acid analogs
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- 5 - Some potential for abuse
- Labeler / Supplier
- Pfizer Inc.
- National Drug Code (NDC)
- 00071-1027
More about Lyrica CR (pregabalin)
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (6)
- Imprints, shape & color data
- Pricing & coupons
- Generic availability
- En español
- Drug class: gamma-aminobutyric acid analogs
Patient resources
Other brands
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.